首页> 外文期刊>JAMA: the Journal of the American Medical Association >Pay-for-Performance Research How to Learn What Clinicians and Policy Makers Need to Know
【24h】

Pay-for-Performance Research How to Learn What Clinicians and Policy Makers Need to Know

机译:绩效绩效研究如何学习临床医生和政策制定者需要知道的内容

获取原文
获取原文并翻译 | 示例
           

摘要

However, the rationale for pay-for-performance comes almost entirely from experience with incentives in other industries. Only 9 randomized controlled trials (RCTs) of pay-for-performance have been reported in the literature.2 Even these studies are not clearly applicable to current pay-for-performance because they all focus on performance for a single indicator or a single aspect of care (eg, preventive care), whereas most current pay-for-performance initiatives use multiple indicators for multiple conditions and types of care.1 Moreover, most studies have important flaws in reporting, such as the failure to note the market share of the organization offering the incentive in the practices of the providers being studied. Because pay-for-performance programs have targeted both individual clinicians and clinical organizations such as hospitals, medical groups, and nursing homes, the collective term "provider" is used herein to refer to all potential parties.
机译:但是,按绩效付费的理由几乎完全来自其他行业的激励措施经验。文献中仅报道了9项绩效绩效的随机对照试验(RCT)。2即使这些研究也不能明确适用于当前的绩效绩效,因为它们都集中于单个指标或单个方面的绩效护理(例如预防护理),而大多数当前的绩效绩效计划针对多种条件和类型使用多个指标。1此外,大多数研究在报告方面存在重要缺陷,例如未能注意到医疗保健的市场份额。在所研究的提供者的实践中提供激励的组织。由于按绩效付费计划既针对个别临床医生又针对诸如医院,医疗团体和疗养院之类的临床组织,因此在此使用统称“提供商”指所有潜在的当事人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号